Cargando…

Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma

Detalles Bibliográficos
Autores principales: Saito, H, Maruyama, D, Maeshima, A M, Makita, S, Kitahara, H, Miyamoto, K, Fukuhara, S, Munakata, W, Suzuki, T, Kobayashi, Y, Taniguchi, H, Tobinai, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775270/
https://www.ncbi.nlm.nih.gov/pubmed/29099480
http://dx.doi.org/10.1038/bcj.2017.100
_version_ 1783293867647303680
author Saito, H
Maruyama, D
Maeshima, A M
Makita, S
Kitahara, H
Miyamoto, K
Fukuhara, S
Munakata, W
Suzuki, T
Kobayashi, Y
Taniguchi, H
Tobinai, K
author_facet Saito, H
Maruyama, D
Maeshima, A M
Makita, S
Kitahara, H
Miyamoto, K
Fukuhara, S
Munakata, W
Suzuki, T
Kobayashi, Y
Taniguchi, H
Tobinai, K
author_sort Saito, H
collection PubMed
description
format Online
Article
Text
id pubmed-5775270
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57752702018-01-23 Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma Saito, H Maruyama, D Maeshima, A M Makita, S Kitahara, H Miyamoto, K Fukuhara, S Munakata, W Suzuki, T Kobayashi, Y Taniguchi, H Tobinai, K Blood Cancer J Corrigendum Nature Publishing Group 2017-11 2017-11-03 /pmc/articles/PMC5775270/ /pubmed/29099480 http://dx.doi.org/10.1038/bcj.2017.100 Text en Copyright © 2017 Macmillan Publishers Limited
spellingShingle Corrigendum
Saito, H
Maruyama, D
Maeshima, A M
Makita, S
Kitahara, H
Miyamoto, K
Fukuhara, S
Munakata, W
Suzuki, T
Kobayashi, Y
Taniguchi, H
Tobinai, K
Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
title Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
title_full Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
title_fullStr Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
title_full_unstemmed Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
title_short Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
title_sort prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent b-cell and mantle cell lymphoma
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775270/
https://www.ncbi.nlm.nih.gov/pubmed/29099480
http://dx.doi.org/10.1038/bcj.2017.100
work_keys_str_mv AT saitoh prolongedlymphocytopeniaafterbendamustinetherapyinpatientswithrelapsedorrefractoryindolentbcellandmantlecelllymphoma
AT maruyamad prolongedlymphocytopeniaafterbendamustinetherapyinpatientswithrelapsedorrefractoryindolentbcellandmantlecelllymphoma
AT maeshimaam prolongedlymphocytopeniaafterbendamustinetherapyinpatientswithrelapsedorrefractoryindolentbcellandmantlecelllymphoma
AT makitas prolongedlymphocytopeniaafterbendamustinetherapyinpatientswithrelapsedorrefractoryindolentbcellandmantlecelllymphoma
AT kitaharah prolongedlymphocytopeniaafterbendamustinetherapyinpatientswithrelapsedorrefractoryindolentbcellandmantlecelllymphoma
AT miyamotok prolongedlymphocytopeniaafterbendamustinetherapyinpatientswithrelapsedorrefractoryindolentbcellandmantlecelllymphoma
AT fukuharas prolongedlymphocytopeniaafterbendamustinetherapyinpatientswithrelapsedorrefractoryindolentbcellandmantlecelllymphoma
AT munakataw prolongedlymphocytopeniaafterbendamustinetherapyinpatientswithrelapsedorrefractoryindolentbcellandmantlecelllymphoma
AT suzukit prolongedlymphocytopeniaafterbendamustinetherapyinpatientswithrelapsedorrefractoryindolentbcellandmantlecelllymphoma
AT kobayashiy prolongedlymphocytopeniaafterbendamustinetherapyinpatientswithrelapsedorrefractoryindolentbcellandmantlecelllymphoma
AT taniguchih prolongedlymphocytopeniaafterbendamustinetherapyinpatientswithrelapsedorrefractoryindolentbcellandmantlecelllymphoma
AT tobinaik prolongedlymphocytopeniaafterbendamustinetherapyinpatientswithrelapsedorrefractoryindolentbcellandmantlecelllymphoma